Nature of blood-labyrinth barrier in experimental conditions.
The blood-labyrinth barrier is concept that has evolved based on marked difference in chemical composition between perilymph and blood. Studies reported here have been designed to manipulate physiologic, metabolic, and pharmacologic conditions in experimental animals in order to determine the characteristics of this regulatory mechanisms. Tracer studies of uptake of sodium, calcium, and albumin from blood into perilymph showed that these substances penetrate into inner ear fluids quite slowly. Injections of ototoxic substances (kanamycin, furosemide) show limited transport of these agents into perilymph. Administration of an osmotic agent (urea) resulted in a parallel but delayed elevation of perilymph concentration. The possible role of a alteration of blood-labyrinth barrier in inner ear disorders has been discussed.
D000818:Animals; D001769:Blood / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000378:metabolism; D002682:Chinchilla; D007758:Ear, Inner / Q000378:metabolism; D005260:Female; D005665:Furosemide / Q000378:metabolism; D007612:Kanamycin / Q000378:metabolism; D007761:Labyrinthine Fluids / Q000378:metabolism*; D008297:Male; D009994:Osmolar Concentration; D010498:Perilymph / Q000378:metabolism*; D012711:Serum Albumin, Radio-Iodinated / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
D012711:Serum Albumin, Radio-Iodinated; D007612:Kanamycin; D005665:Furosemide; D012964:Sodium; D002118:Calcium